Guadarrama-Díaz EO, García-Roca MIP, Reyes-Pérez H, Medeiros M

Language: Spanish
References: 17
Page: 209-215
PDF size: 165.27 Kb.

ABSTRACT

Background. Tacrolimus is a widely used immunosuppressant in renal transplant patients. Drug monitoring is performed by measuring trough levels. Pharmacodynamic monitoring is used to evaluate the biological effect.
The aim of the study was to determine the relationship between tacrolimus area-under concentration vs. time curve (AUC) and the gene expression of tumor necrosis factor alpha (TNF-α) in children with renal transplant.
Methods. An experimental, cross-sectional study was performed in children with renal transplant at 3 months after transplant. An 8-h pharmacokinetic–pharmacodynamic profile was obtained. Gene expression of TNF-α and internal control of 18s rRNA was performed by real-time PCR. CYP3A5 genotype was obtained by direct sequencing.
Results. Six patients were included with a median age of 14.5 years. A negative correlation was found between tacrolimus pharmacokinetics and TNF-α gene expression. There was a trend of low TNF-α with high tacrolimus blood levels.
Conclusions. There is a negative correlation between tacrolimus concentration and TNF-α gene expression. TNF-α gene expression was not modified by CYP3A5 genotype.

REFERENCES

1. Danovich GM. Handbook of Kidney Trasnplantation. Philadelphia: Lippincott Williams & Wilkins; 2010.

2. 2. Alberú-Gómez J, Morales-Buenrostro LE, Abbud-Filho M. Trasplantomecum Renal. Barcelona: Permanyer; 2011.

3. 3. Reyes-Pérez H, Medeiros-Domingo M. Uso de tacrolimus en pediatría. Bol Med Hosp Infant Mex 2006;63:276-285.

4. 4. García-Roca P, Medeiros M, Reyes H, Rodríguez-Espino BA, Alberú J, Ortiz L, et al. CYP3A5 polymorphism in Mexican renal transplant recipients and its association with tacrolimus dosing. Arch Med Res 2012;43:283-287.

5. 5. Midtvedt K, Fauchald P, Bergan S, Høieggen A, Hallan S, Svarstad E, et al. C2 monitoring in maintenance renal transplant recipients: is it worthwhile? Transplantation 2003;76:1236-1238.

6. 6. Einecke G, Mai I, Fritsche L, Slowinski T, Waiser J, Neumayer HH, et al. The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression. Nephrol Dial Transplant 2004;19:215-222.

7. 7. Morris RG, Russ GR, Cervelli MJ, Juneja R, McDonald SP, Mathew TH. Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month. Ther Drug Monit 2002;24:479-486.

8. 8. Sommerer C, Giese T, Meuer S, Zeier M. New concepts to individualize calcineurin inhibitor therapy in renal allograft recipients. Saudi J Kidney Dis Transpl 2010;21:1030-1037.

9. 9. Halloran PF, Helms LM, Kung L, Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 1999;68:1356-1361.

10. Giese T, Zeier M, Schemmer P, Uhl W, Schoels M, Dengler T, et al. Monitoring of NFAT-regulated gene expression in the peripheral blood of allograft recipients: a novel perspective toward individually optimized drug doses of cyclosporine A. Transplantation 2004;77:339-344.

11. Sommerer C, Konstandin M, Dengler T, Schmidt J, Meuer S, Zeier M, et al. Pharmacodynamic monitoring of cyclosporine A in renal allograft recipients shows a quantitative relationship between immunosuppression and the occurrence of recurrent infections and malignancies. Transplantation 2006;82:1280-1285.

12. Sommerer C, Giese T, Schmidt J, Meuer S, Zeier M. Ciclosporin A tapering monitored by NFAT-regulated gene expression: a new concept of individual immunosuppression. Transplantation 2008;85:15-21.

13. Sommerer C, Morath C, Giese T, Meuer S, Zeier M. Activity of nuclear factor of activated T cells is independent of the number of peripheral lymphocytes in FTY720-treated patients. Transplant Proc 2008;40:1416-1418.

14. Sommerer C, Zeier M, Meuer S, Giese T. Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients. Transplantation 2010;89:1417-1423.

15. Schwartz GJ, Haycock GB, Spitzer A. Plasma creatinine and urea concentration in children: normal values for age and sex. J Pediatr 1976;88:828-830.

16. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987;34:571-590.

17. Schwartz GJ, Furth SL. Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol 2007;22:1839-1848.